We are building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders using information captured with a standard smartphone or webcam.
Presently, neurological evaluation is highly subjective, non-sensitive, and depends on manual examination of symptoms. This poses a significant challenge for treatment development and precision care.
Our vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively, and people live longer, healthier lives.
This challenge applies to a wide scope of neurological disorders, including Alzheimer's, Parkinson's Disease, and Multiple Sclerosis, among others.
Our AI-driven platform automatically extracts micro-oculometrics, providing objective and sensitive digital markers for neurological disorders.
Our solution will serve as a robust proxy for currently used endpoints, and ultimately define a new measurement standard, paving the path for precision medicine in neurology.
We are building the world’s largest, proprietary, de-identified oculometric database. We then apply AI to surface big data insights to empower true personalization in neurological care.
We are working with some of the worlds greatest minds including Nobel laureates to take this science one step further, and establish more robust models and accurate endpoints.